FHIRsmith: ValueSet/ValueSet-R4-v3-substanceAdminSubstitution-for-R5.json

FHIR © HL7.org |

FHIRsmith 4.0.1 | Server Home | XIG Home | XIG Stats |

FHIR IG analytics

Package	hl7.fhir.uv.xver-r4.r5
Resource Type	ValueSet
Id	ValueSet-R4-v3-substanceAdminSubstitution-for-R5.json
FHIR Version	R5
Source	http://hl7.org/fhir/uv/xver-r4.r5/0.1.0/ValueSet-R4-v3-substanceAdminSubstitution-for-R5.html
URL	http://hl7.org/fhir/uv/xver/ValueSet/R4-v3-substanceAdminSubstitution-for-R5
Version	0.1.0
Status	active
Date	2026-03-17T21:02:03.8104715+00:00
Name	R4V3SubstanceAdminSubstitutionForR5
Title	Cross-version ValueSet R4.v3.substanceAdminSubstitution for use in FHIR R5
Realm	uv
Authority	hl7
Description	This cross-version ValueSet represents content from `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution\|2018-08-12` for use in FHIR R5.
Purpose	This value set is part of the cross-version definitions generated to enable use of the value set `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution\|2018-08-12` as defined in FHIR R4 in FHIR R5. The source value set is bound to the following FHIR R4 elements: * Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: FHIR ValueSet `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution\|2018-08-12`, defined in FHIR R4 does not have any mapping to FHIR R5

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
hl7.terminology#current	v3-substanceAdminSubstitution	Substance Admin Substitution

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet R4-v3-substanceAdminSubstitution-for-R5

This value set expansion contains 10 concepts.

System	Version	Code	Display	Definition
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	BC	brand composition	Description: `Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven`
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	E	equivalent	Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	EC	equivalent composition	Description: `Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril`
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	F	formulary	Description: This substitution was performed or is permitted based on formulary guidelines.
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	G	generic composition	Description: Substitution occurred or is permitted between equivalent Generics but not Brands `Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)`
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	N	none	No substitution occurred or is permitted.
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	TB	therapeutic brand	Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics `Examples: Zantac for Tagamet`
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	TE	therapeutic alternative	Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. `Examples: ranitidine for Tagamet`
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	TG	therapeutic generic	Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands `Examples: Ranitidine for cimetidine`
`http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution`	2018-08-12	_ActSubstanceAdminSubstitutionCode	ActSubstanceAdminSubstitutionCode	Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

Source1

{
  "resourceType": "ValueSet",
  "id": "R4-v3-substanceAdminSubstitution-for-R5",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 0
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "vocab"
    },
    {
      "extension": [
        {
          "url": "packageId",
          "valueId": "hl7.fhir.uv.xver-r4.r5"
        },
        {
          "url": "version",
          "valueString": "0.1.0"
        },
        {
          "url": "uri",
          "valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r4.r5"
        }
      ],
      "url": "http://hl7.org/fhir/StructureDefinition/package-source"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use",
      "_valueCode": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r4.r5"
          }
        ]
      }
    }
  ],
  "url": "http://hl7.org/fhir/uv/xver/ValueSet/R4-v3-substanceAdminSubstitution-for-R5",
  "version": "0.1.0",
  "name": "R4V3SubstanceAdminSubstitutionForR5",
  "title": "Cross-version ValueSet R4.v3.substanceAdminSubstitution for use in FHIR R5",
  "status": "active",
  "experimental": false,
  "date": "2026-03-17T21:02:03.8104715+00:00",
  "publisher": "HL7 International / Terminology Infrastructure",
  "contact": [
    {
      "name": "HL7 International / Terminology Infrastructure",
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/Vocab"
        }
      ]
    }
  ],
  "description": "This cross-version ValueSet represents content from `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution|2018-08-12` for use in FHIR R5.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001",
          "display": "World"
        }
      ]
    }
  ],
  "purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution|2018-08-12` as defined in FHIR R4\r\nin FHIR R5.\r\n\r\nThe source value set is bound to the following FHIR R4 elements:\r\n* \r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\n\nFHIR ValueSet `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution|2018-08-12`, defined in FHIR R4 does not have any mapping to FHIR R5",
  "compose": {
    "include": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "concept": [
          {
            "code": "BC",
            "display": "brand composition"
          },
          {
            "code": "E",
            "display": "equivalent"
          },
          {
            "code": "EC",
            "display": "equivalent composition"
          },
          {
            "code": "F",
            "display": "formulary"
          },
          {
            "code": "G",
            "display": "generic composition"
          },
          {
            "code": "N",
            "display": "none"
          },
          {
            "code": "TB",
            "display": "therapeutic brand"
          },
          {
            "code": "TE",
            "display": "therapeutic alternative"
          },
          {
            "code": "TG",
            "display": "therapeutic generic"
          },
          {
            "code": "_ActSubstanceAdminSubstitutionCode",
            "display": "ActSubstanceAdminSubstitutionCode"
          }
        ]
      }
    ]
  },
  "expansion": {
    "timestamp": "2026-03-17T21:02:03.8104715+00:00",
    "contains": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "BC",
        "display": "brand composition"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "E",
        "display": "equivalent"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "EC",
        "display": "equivalent composition"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "F",
        "display": "formulary"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "G",
        "display": "generic composition"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "N",
        "display": "none"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "TB",
        "display": "therapeutic brand"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "TE",
        "display": "therapeutic alternative"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "TG",
        "display": "therapeutic generic"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
        "version": "2018-08-12",
        "code": "_ActSubstanceAdminSubstitutionCode",
        "display": "ActSubstanceAdminSubstitutionCode"
      }
    ]
  }
}

FHIR © HL7.org 2011+. | FHIRsmith 4.0.1 © HealthIntersections.com.au 2023+ | XIG built as of 2026-04-07 | 262,381 resources in 1,414 packages | (170 ms)